For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...
Surprisingly, early-stage CTE showed no link to cognitive decline In A Nutshell CTE severity had no link to depression, ...
While the latest UK Government report into animal testing was keen to highlight a (very slight) decrease from 2.67 million ...
Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...
If you walk down the aisles of the supermarket today, there often seems to be your favourite food, but better. Protein pancakes, collagen smoothies, prebiotic lemonades. This influx appears driven by ...
In A Nutshell Harvard researchers developed BrainIAC, a single AI model that can be adapted to analyze brain scans for ...
A new AI foundation model from Mass General Brigham may be capable of analyzing brain MRI datasets and predict various ...
BrainIAC, a breakthrough AI foundation model, is able to predict brain age, dementia, time-to-stroke, and brain cancer from brain magnetic resonance imaging (MRI).
Neurons from grafted stem cells contain intrinsic codes for navigating and forming connections, which may improve cell therapy for a brain short-circuited by stroke. Some parts of our bodies bounce ...
In a study published in Cell Research, researchers have identified a fibrous-layer resident subpopulation of P-SSCs labeled by Angptl7. They found that these cells are crucial for bone fracture repair ...
Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...
Clinical Trials Arena on MSN
Bausch Health’s new formulation of Xifaxan fails pair of Phase III trials
Rifaximin SSD failed to significantly delay the onset of HE in patients with liver cirrhosis, but Bausch is yet to scrap the molecule’s development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results